newsfilter
← Latest News
GlobeNewswire·

Altamira Therapeutics Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement

- Partial spin-off of Bentrio® completed to increase focus on RNA delivery activities - Retains 49% in Altamira Medica AG, and secures 25% of future licensing revenue HAMILTON, BERMUDA, Nov. 29, 2023 (GLOBE